Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibodies and tuberculosis
Ashley J. Jacobs, Juthathip Mongkolsapaya, Gavin Screaton, et al.
Tuberculosis (2016) Vol. 101, pp. 102-113
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Immune Response to Mycobacterium tuberculosis: A Narrative Review
Maurizio de Martino, Lorenzo Lodi, Luisa Galli, et al.
Frontiers in Pediatrics (2019) Vol. 7
Open Access | Times Cited: 279
Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control
Hannah P. Gideon, Travis K. Hughes, Constantine N. Tzouanas, et al.
Immunity (2022) Vol. 55, Iss. 5, pp. 827-846.e10
Open Access | Times Cited: 176
Diagnosis for Latent Tuberculosis Infection: New Alternatives
Claudia Carranza, Sigifredo Pedraza‐Sánchez, Eleane de Oyarzabal-Mendez, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 155
The knowns and unknowns of latent Mycobacterium tuberculosis infection
W. Henry Boom, Ulrich E. Schaible, Jacqueline M. Achkar
Journal of Clinical Investigation (2021) Vol. 131, Iss. 3
Open Access | Times Cited: 105
Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis
Birhanu Ayelign, Markos Negash, Meaza Genetu, et al.
Journal of Immunology Research (2019) Vol. 2019, pp. 1-8
Open Access | Times Cited: 135
Host-Directed Therapeutic Strategies for Tuberculosis
Afsal Kolloli, Selvakumar Subbian
Frontiers in Medicine (2017) Vol. 4
Open Access | Times Cited: 123
The Humoral Immune Response to BCG Vaccination
Rachel Tanner, Bernardo Villarreal‐Ramos, H. Martin Vordermeier, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 114
The current status, challenges, and future developments of new tuberculosis vaccines
Wenping Gong, Yan Liang, Xueqiong Wu
Human Vaccines & Immunotherapeutics (2018) Vol. 14, Iss. 7, pp. 1697-1716
Open Access | Times Cited: 112
The Immune Response toMycobacterium tuberculosisin HIV-1-Coinfected Persons
Hanif Esmail, Catherine Riou, Elsa Du Bruyn, et al.
Annual Review of Immunology (2018) Vol. 36, Iss. 1, pp. 603-638
Open Access | Times Cited: 102
Tuberculosis vaccines: Opportunities and challenges
Bingdong Zhu, Hazel M. Dockrell, Tom H. M. Ottenhoff, et al.
Respirology (2018) Vol. 23, Iss. 4, pp. 359-368
Open Access | Times Cited: 90
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis
Willemijn Rijnink, Tom H. M. Ottenhoff, Simone A. Joosten
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 77
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults
Morven Wilkie, Iman Satti, Alice Minhinnick, et al.
Vaccine (2019) Vol. 38, Iss. 4, pp. 779-789
Open Access | Times Cited: 73
Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
Richard W. Titball, Mary N. Burtnick, Gregory J. Bancroft, et al.
Vaccine (2017) Vol. 35, Iss. 44, pp. 5981-5989
Open Access | Times Cited: 71
BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny
Asimenia Angelidou, Joann Diray‐Arce, Maria Giulia Conti, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 68
Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge
Manli Wu, Haoxin Zhao, Min Li, et al.
Frontiers in Cellular and Infection Microbiology (2017) Vol. 7
Open Access | Times Cited: 66
Biomarkers for tuberculosis: the case for lipoarabinomannan
Margarida Correia‐Neves, Gabrielle Fröberg, Liudmyla Korshun, et al.
ERJ Open Research (2019) Vol. 5, Iss. 1, pp. 00115-2018
Open Access | Times Cited: 57
Role of B Cells in Mycobacterium Tuberculosis Infection
Paul A. Stewart, Shivani Patel, Andrew Comer, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 955-955
Open Access | Times Cited: 16
Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin
Alastair Copland, Gil R. Diogo, Peter Hart, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 51
Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
Elena Stylianou, Matthew J. Paul, Rajko Reljić, et al.
Expert Review of Vaccines (2019) Vol. 18, Iss. 12, pp. 1271-1284
Open Access | Times Cited: 47
Lipoarabinomannan in Active and Passive Protection Against Tuberculosis
Margarida Correia‐Neves, Christopher Sundling, Andrea M. Cooper, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 45
A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis
Jeffrey Kawahara, Edward B. Irvine, Galit Alter
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 44
The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins
Hussain A. Safar, Abu Salim Mustafa, Hanady A. Amoudy, et al.
PLoS ONE (2020) Vol. 15, Iss. 2, pp. e0228381-e0228381
Open Access | Times Cited: 41
Therapeutic Effect of Subunit Vaccine AEC/BC02 on Mycobacterium tuberculosis Post-Chemotherapy Relapse Using a Latent Infection Murine Model
Jinbiao Lu, Xiaonan Guo, Chunhua Wang, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 825-825
Open Access | Times Cited: 24
Synergy between Th1 and Th2 responses duringMycobacterium tuberculosisinfection: A review of current understanding
Fekadu Abebe
International Reviews of Immunology (2019) Vol. 38, Iss. 4, pp. 172-179
Closed Access | Times Cited: 41
Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis
Jacqueline M. Achkar, Rafael Prados‐Rosales
Current Opinion in Immunology (2018) Vol. 53, pp. 30-37
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top